Current progress in bionanomaterials to modulate the epigenome

Anna D.Y. Rhodes, Jose Antonio Duran-Mota, Nuria Oliva

Producció científica: Article en revista indexadaArticle de revisió (sistemàtica)Avaluat per experts

3 Cites (Scopus)


Recent advances in genomics during the 1990s have made it possible to study and identify genetic and epigenetic responses of cells and tissues to various drugs and environmental factors. This has accelerated the number of targets available to treat a range of diseases from cancer to wound healing disorders. Equally interesting is the understanding of how bio- and nanomaterials alter gene expression through epigenetic mechanisms, and whether they have the potential to elicit a positive therapeutic response without requiring additional biomolecule delivery. In fact, from a cell's perspective, a biomaterial is nothing more than an environmental factor, and so it has the power to epigenetically modulate gene expression of cells in contact with it. Understanding these epigenetic interactions between biomaterials and cells will open new avenues in the development of technologies that can not only provide biological signals (i.e. drugs, growth factors) necessary for therapy and regeneration, but also intimately interact with cells to promote the expression of genes of interest. This review article aims to summarise the current state-of-the-art and progress on the development of bio- and nanomaterials to modulate the epigenome.

Idioma originalAnglès
Pàgines (de-a)5081-5091
Nombre de pàgines11
RevistaBiomaterials Science
Estat de la publicacióPublicada - 21 de jul. 2022
Publicat externament


Navegar pels temes de recerca de 'Current progress in bionanomaterials to modulate the epigenome'. Junts formen un fingerprint únic.

Com citar-ho